Remzi Önder

497 total citations
23 papers, 316 citations indexed

About

Remzi Önder is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Remzi Önder has authored 23 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Remzi Önder's work include Blood Pressure and Hypertension Studies (9 papers), Hormonal Regulation and Hypertension (6 papers) and Cardiovascular Function and Risk Factors (5 papers). Remzi Önder is often cited by papers focused on Blood Pressure and Hypertension Studies (9 papers), Hormonal Regulation and Hypertension (6 papers) and Cardiovascular Function and Risk Factors (5 papers). Remzi Önder collaborates with scholars based in Türkiye and Italy. Remzi Önder's co-authors include Sanem Nalbantgil, İstemi Nalbantgil, Filiz Özerkan, Mehdi Zoghi, Hasan Yılmaz, Azem Akıllı, Mustafa Akın, Hamza Duygu, İstemihan Tengiz and Francesco Fıcı and has published in prestigious journals such as American Journal of Hypertension, Journal of the American Society of Echocardiography and International Journal of Clinical Practice.

In The Last Decade

Remzi Önder

23 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Remzi Önder Türkiye 11 243 99 83 76 49 23 316
İstemi Nalbantgil Türkiye 11 238 1.0× 63 0.6× 84 1.0× 65 0.9× 43 0.9× 34 337
Andrew Sharp United Kingdom 7 215 0.9× 48 0.5× 33 0.4× 32 0.4× 36 0.7× 12 303
C PORCELLATI Italy 8 428 1.8× 55 0.6× 98 1.2× 61 0.8× 12 0.2× 10 511
Neal Klein United States 10 341 1.4× 84 0.8× 34 0.4× 46 0.6× 44 0.9× 14 477
Peter B. Bottini United States 12 377 1.6× 91 0.9× 47 0.6× 184 2.4× 20 0.4× 24 593
M Radice Italy 12 328 1.3× 109 1.1× 61 0.7× 82 1.1× 10 0.2× 32 439
Andrew S.P. Sharp United Kingdom 9 482 2.0× 82 0.8× 53 0.6× 84 1.1× 35 0.7× 16 533
Donald Hall Germany 9 287 1.2× 84 0.8× 22 0.3× 34 0.4× 12 0.2× 15 374
FG Dunn United Kingdom 9 242 1.0× 75 0.8× 52 0.6× 44 0.6× 10 0.2× 25 360
Ali Khavandi United Kingdom 8 178 0.7× 65 0.7× 51 0.6× 54 0.7× 12 0.2× 20 314

Countries citing papers authored by Remzi Önder

Since Specialization
Citations

This map shows the geographic impact of Remzi Önder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Remzi Önder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Remzi Önder more than expected).

Fields of papers citing papers by Remzi Önder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Remzi Önder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Remzi Önder. The network helps show where Remzi Önder may publish in the future.

Co-authorship network of co-authors of Remzi Önder

This figure shows the co-authorship network connecting the top 25 collaborators of Remzi Önder. A scholar is included among the top collaborators of Remzi Önder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Remzi Önder. Remzi Önder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duygu, Hamza, Levent Akman, Filiz Özerkan, et al.. (2009). Comparison of the effects of new and conventional hormone replacement therapies on left ventricular diastolic function in healthy postmenopausal women: a Doppler and ultrasonic backscatter study. International journal of cardiac imaging. 25(4). 387–396. 12 indexed citations
2.
Duygu, Hamza, Mehdi Zoghi, Sanem Nalbantgil, et al.. (2008). Apical hypertrophic cardiomyopathy might lead to misdiagnosis of ischaemic heart disease. International journal of cardiac imaging. 24(7). 675–681. 15 indexed citations
3.
Duygu, Hamza, Mehdi Zoghi, Uğur Önsel Türk, et al.. (2008). The Role of Tilt Training in Preventing Recurrent Syncope in Patients with Vasovagal Syncope: A Prospective and Randomized Study. Pacing and Clinical Electrophysiology. 31(5). 592–596. 48 indexed citations
4.
Duygu, Hamza, Filiz Özerkan, Mehdi Zoghi, et al.. (2007). Objective Ischemic Evidence in Patients with Myocardial Bridging: Ultrasonic Tissue Characterization with Dobutamine Stress Integrated Backscatter. Journal of the American Society of Echocardiography. 20(6). 717–723. 7 indexed citations
5.
Barış, Nezihi, Bahri Akdeniz, Filiz Özerkan, et al.. (2006). The Relationship Between Hypertensive Retinopathy and Angiotensin Converting Enzyme Gene Polymorphism. Cardiovascular & Haematological Disorders - Drug Targets. 6(1). 57–61. 3 indexed citations
6.
Nalbantgil, Sanem, Francesco Fıcı, İstemi Nalbantgil, et al.. (2005). A Randomised Comparison of the Effects of Nebivolol and Atenolol with and without Chlorthalidone on??the Sexual Function of Hypertensive Men. Clinical Drug Investigation. 25(6). 409–416. 61 indexed citations
7.
Nalbantgil, Sanem, et al.. (2005). The effect of trimetazidine in the treatment of microvascular angina. International Journal of Angiology. 8(1). 40–43. 26 indexed citations
8.
9.
Nalbantgil, Sanem, Mehdi Zoghi, Filiz Özerkan, et al.. (2003). Comparison of candesartan and felodipine alone and combined in the treatment of hypertension: a single-center, double-blind, randomized, crossover trial. Current Therapeutic Research. 64(7). 380–388. 1 indexed citations
10.
Nalbantgil, Sanem, İstemi Nalbantgil, & Remzi Önder. (2000). Clinically additive effect between doxazosin and amlodipine in the treatment of essential hypertension. American Journal of Hypertension. 13(8). 921–926. 16 indexed citations
11.
12.
Nalbantgil, Sanem, et al.. (1999). The Effect of Trimetazidine in the Treatment of Microvascular Angina. International Journal of Angiology. 8(1). 40–43. 20 indexed citations
13.
Nalbantgil, Sanem, et al.. (1999). The effect of trimetazidine in the treatment of microvascular angina. International Journal of Angiology. 8(1). 40–43. 3 indexed citations
14.
Nalbantgil, İstemi, et al.. (1998). Therapeutic Benefits of Cilazapril in Patients with Syndrome X. Cardiology. 89(2). 130–133. 31 indexed citations
15.
Nalbantgil, İstemi, et al.. (1996). The Efficacy of Felodipine ER on Regression of Left Ventricular Hypertrophy in Patients with Primary Hypertension. Blood Pressure. 5(5). 285–291. 6 indexed citations
16.
Nalbantgil, İstemi, Remzi Önder, & Sanem Nalbantgil. (1996). Sustained-release verapamil and trandolapril, alone and in combination, in the treatment of obese hypertensive patients: a double-blind pilot study. Current Therapeutic Research. 57(12). 990–997. 7 indexed citations
17.
18.
Nalbantgil, İstemi, et al.. (1993). The Effect of Age and Sex on White-coat Hypertension. Archives of the Turkish Society of Cardiology. 21(3). 182–183. 1 indexed citations
19.
Nalbantgil, İstemi, et al.. (1993). Evaluation of the antihypertensive effect of amlodipine using 24-hour ambulatory blood pressure measurement. Current Therapeutic Research. 53(6). 621–629. 3 indexed citations
20.
Nalbantgil, İstemi, et al.. (1993). Combination therapy with verapamil and nitrendipine in patients with hypertension.. PubMed. 7(3). 305–8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by İstemi Nalbantgil Breakdown of academic impact, for papers by Andrew Sharp Breakdown of academic impact, for papers by C PORCELLATI Breakdown of academic impact, for papers by Neal Klein Breakdown of academic impact, for papers by Peter B. Bottini Breakdown of academic impact, for papers by M Radice Breakdown of academic impact, for papers by Andrew S.P. Sharp Breakdown of academic impact, for papers by Donald Hall Breakdown of academic impact, for papers by FG Dunn Breakdown of academic impact, for papers by Ali Khavandi
Rankless by CCL
2026